_id
690daf26ccc777a4e85d0ae4
Ticker
ANRO
Name
Alto Neuroscience, Inc.
Exchange
NYSE
Address
650 Castro Street, Mountain View, CA, United States, 94041
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.altoneuroscience.com
Description
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties, which is in Phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor that is in Phase 2 proof-of-concept (POC) trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist, which is in Phase 2 POC trial to treat patients with MDD and higher levels of anhedonia; and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor that is in Phase 1 clinical trial for the treatment of MDD. The company was incorporated in 2019 and is headquartered in Mountain View, California.
Last Close
16.83
Volume
18855
Current Price
17.18
Change
0.01
Last Updated
2026-01-20T15:26:16.070Z
Image
data:image/webp;base64,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
Ipo Date
2024-02-02T00:00:00.000Z
Market Cap
533408992
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-0.935
Sentiment Sources
1
Rating
4.625
Target Price
31.125
Strong Buy
6
Buy
1
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
164000
Gross Profit
-164000
Operating Expenses
14787000
Operating Income
-14951000
Interest Expense
650000
Pretax Income
-14181000
Net Income
-14181000
Eps
-0.523206906729634
Dividends Per Share
-
Shares Outstanding
31066335
Income Tax Expense
-
EBITDA
-13367000
Operating Margin
-
Total Other Income Expense Net
770000
Cash
137816000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
139448000
Property Plant Equipment
6488000
Total Assets
147006000
Payables
2059000
Short Term Debt
1118000
Long Term Debt
22438000
Total Liabilities
35449000
Equity
111557000
Bs_currency_symbol
USD
Depreciation
164000
Change In Working Capital
1297000
Cash From Operations
-9918000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
153000
Net Change In Cash
-9769000
Cf_currency_symbol
USD
PE
-
PB
4.174069937341448
ROE
-12.711887196679724
ROA
-9.646545038978001
FCF
-9918000
Fcf Percent
-
Piotroski FScore
1
Health Score
38
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3
Net Net Investing Score
1.5
Quality Investing Score
3
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
164000
Quarters > 0 > income Statement > gross Profit
-164000
Quarters > 0 > income Statement > operating Expenses
14787000
Quarters > 0 > income Statement > operating Income
-14951000
Quarters > 0 > income Statement > interest Expense
650000
Quarters > 0 > income Statement > pretax Income
-14181000
Quarters > 0 > income Statement > net Income
-14181000
Quarters > 0 > income Statement > eps
-0.523206906729634
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
27104000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-13367000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
770000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
137816000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
139448000
Quarters > 0 > balance Sheet > property Plant Equipment
6488000
Quarters > 0 > balance Sheet > total Assets
147006000
Quarters > 0 > balance Sheet > payables
2059000
Quarters > 0 > balance Sheet > short Term Debt
1118000
Quarters > 0 > balance Sheet > long Term Debt
22438000
Quarters > 0 > balance Sheet > total Liabilities
35449000
Quarters > 0 > balance Sheet > equity
111557000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-14181000
Quarters > 0 > cash Flow > depreciation
164000
Quarters > 0 > cash Flow > change In Working Capital
1297000
Quarters > 0 > cash Flow > cash From Operations
-9918000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
153000
Quarters > 0 > cash Flow > net Change In Cash
-9769000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.523206906729634
Quarters > 0 > ratios > PB
4.174069937341448
Quarters > 0 > ratios > ROE
-12.711887196679724
Quarters > 0 > ratios > ROA
-9.646545038978001
Quarters > 0 > ratios > FCF
-9918000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
38
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
100000
Quarters > 1 > income Statement > gross Profit
-100000
Quarters > 1 > income Statement > operating Expenses
18582000
Quarters > 1 > income Statement > operating Income
-18682000
Quarters > 1 > income Statement > interest Expense
646000
Quarters > 1 > income Statement > pretax Income
-17706000
Quarters > 1 > income Statement > net Income
-17706000
Quarters > 1 > income Statement > eps
-0.6540336879432624
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
27072000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-16960000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
976000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
147585000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
149846000
Quarters > 1 > balance Sheet > property Plant Equipment
6961000
Quarters > 1 > balance Sheet > total Assets
157877000
Quarters > 1 > balance Sheet > payables
1671000
Quarters > 1 > balance Sheet > short Term Debt
973000
Quarters > 1 > balance Sheet > long Term Debt
22122000
Quarters > 1 > balance Sheet > total Liabilities
34465000
Quarters > 1 > balance Sheet > equity
123412000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-17706000
Quarters > 1 > cash Flow > depreciation
169000
Quarters > 1 > cash Flow > change In Working Capital
1295000
Quarters > 1 > cash Flow > cash From Operations
-13779000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
613000
Quarters > 1 > cash Flow > net Change In Cash
-13169000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.6540336879432624
Quarters > 1 > ratios > PB
3.7686526431789455
Quarters > 1 > ratios > ROE
-14.347065115223803
Quarters > 1 > ratios > ROA
-11.21505982505368
Quarters > 1 > ratios > FCF
-13779000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
38
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
171000
Quarters > 2 > income Statement > gross Profit
-171000
Quarters > 2 > income Statement > operating Expenses
15676000
Quarters > 2 > income Statement > operating Income
-15676000
Quarters > 2 > income Statement > interest Expense
598000
Quarters > 2 > income Statement > pretax Income
-15169000
Quarters > 2 > income Statement > net Income
-15169000
Quarters > 2 > income Statement > eps
-0.5607970719804799
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
27049000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-14400000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
507000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
160754000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
163523000
Quarters > 2 > balance Sheet > property Plant Equipment
7323000
Quarters > 2 > balance Sheet > total Assets
171915000
Quarters > 2 > balance Sheet > payables
1384000
Quarters > 2 > balance Sheet > short Term Debt
876000
Quarters > 2 > balance Sheet > long Term Debt
21151000
Quarters > 2 > balance Sheet > total Liabilities
32819000
Quarters > 2 > balance Sheet > equity
139096000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-15169000
Quarters > 2 > cash Flow > depreciation
171000
Quarters > 2 > cash Flow > change In Working Capital
-4659000
Quarters > 2 > cash Flow > cash From Operations
-16556000
Quarters > 2 > cash Flow > capital Expenditures
24000
Quarters > 2 > cash Flow > cash From Investing
-24000
Quarters > 2 > cash Flow > cash From Financing
9127000
Quarters > 2 > cash Flow > net Change In Cash
-7475000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.5607970719804799
Quarters > 2 > ratios > PB
3.3408711968712255
Quarters > 2 > ratios > ROE
-10.905417840915627
Quarters > 2 > ratios > ROA
-8.8235465200826
Quarters > 2 > ratios > FCF
-16580000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
37
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
394000
Quarters > 3 > income Statement > cost Of Revenue
170000
Quarters > 3 > income Statement > gross Profit
-170000
Quarters > 3 > income Statement > operating Expenses
16827000
Quarters > 3 > income Statement > operating Income
-16997000
Quarters > 3 > income Statement > interest Expense
333000
Quarters > 3 > income Statement > pretax Income
-15201000
Quarters > 3 > income Statement > net Income
-15201000
Quarters > 3 > income Statement > eps
-0.5632803884600335
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
26986560
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-14698000
Quarters > 3 > income Statement > operating Margin
-4313.959390862944
Quarters > 3 > income Statement > total Other Income Expense Net
1796000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
168229000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
169337000
Quarters > 3 > balance Sheet > property Plant Equipment
7701000
Quarters > 3 > balance Sheet > total Assets
177542000
Quarters > 3 > balance Sheet > payables
1579000
Quarters > 3 > balance Sheet > short Term Debt
870000
Quarters > 3 > balance Sheet > long Term Debt
11558000
Quarters > 3 > balance Sheet > total Liabilities
26082000
Quarters > 3 > balance Sheet > equity
151460000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-15201000
Quarters > 3 > cash Flow > depreciation
170000
Quarters > 3 > cash Flow > change In Working Capital
99000
Quarters > 3 > cash Flow > cash From Operations
-13021000
Quarters > 3 > cash Flow > capital Expenditures
506000
Quarters > 3 > cash Flow > cash From Investing
-506000
Quarters > 3 > cash Flow > cash From Financing
49000
Quarters > 3 > cash Flow > net Change In Cash
-13472000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.5632803884600335
Quarters > 3 > ratios > PB
3.0610662934108017
Quarters > 3 > ratios > ROE
-10.036313218011356
Quarters > 3 > ratios > ROA
-8.561917743407193
Quarters > 3 > ratios > FCF
-13527000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-34.33248730964467
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-09-30
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
502000
Annuals > 0 > income Statement > gross Profit
-502000
Annuals > 0 > income Statement > operating Expenses
68108000
Annuals > 0 > income Statement > operating Income
-68610000
Annuals > 0 > income Statement > interest Expense
1375000
Annuals > 0 > income Statement > pretax Income
-61431000
Annuals > 0 > income Statement > net Income
-61431000
Annuals > 0 > income Statement > eps
-2.496992114462239
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
24602000
Annuals > 0 > income Statement > income Tax Expense
-61431000
Annuals > 0 > income Statement > EBITDA
-68610000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
7179000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
168229000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
169337000
Annuals > 0 > balance Sheet > property Plant Equipment
7701000
Annuals > 0 > balance Sheet > total Assets
177542000
Annuals > 0 > balance Sheet > payables
1579000
Annuals > 0 > balance Sheet > short Term Debt
870000
Annuals > 0 > balance Sheet > long Term Debt
11558000
Annuals > 0 > balance Sheet > total Liabilities
26082000
Annuals > 0 > balance Sheet > equity
151460000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-61431000
Annuals > 0 > cash Flow > depreciation
502000
Annuals > 0 > cash Flow > change In Working Capital
4060000
Annuals > 0 > cash Flow > cash From Operations
-47424000
Annuals > 0 > cash Flow > capital Expenditures
2075000
Annuals > 0 > cash Flow > cash From Investing
-2075000
Annuals > 0 > cash Flow > cash From Financing
135691000
Annuals > 0 > cash Flow > net Change In Cash
86181000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-2.496992114462239
Annuals > 0 > ratios > PB
2.7905873497953255
Annuals > 0 > ratios > ROE
-40.559223557374885
Annuals > 0 > ratios > ROA
-34.60082684660531
Annuals > 0 > ratios > FCF
-49499000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-09-30
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
373000
Annuals > 1 > income Statement > gross Profit
-373000
Annuals > 1 > income Statement > operating Expenses
37809000
Annuals > 1 > income Statement > operating Income
-37809000
Annuals > 1 > income Statement > interest Expense
1370000
Annuals > 1 > income Statement > pretax Income
-36305000
Annuals > 1 > income Statement > net Income
-36305000
Annuals > 1 > income Statement > eps
-1.3504320861919743
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
26883988
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-34562000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
1504000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
82548000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
8000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
85391000
Annuals > 1 > balance Sheet > property Plant Equipment
1106000
Annuals > 1 > balance Sheet > total Assets
86628000
Annuals > 1 > balance Sheet > payables
1074000
Annuals > 1 > balance Sheet > short Term Debt
125000
Annuals > 1 > balance Sheet > long Term Debt
9861000
Annuals > 1 > balance Sheet > total Liabilities
158300000
Annuals > 1 > balance Sheet > equity
-71672000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-36305000
Annuals > 1 > cash Flow > depreciation
373000
Annuals > 1 > cash Flow > change In Working Capital
-698000
Annuals > 1 > cash Flow > cash From Operations
-33448000
Annuals > 1 > cash Flow > capital Expenditures
470000
Annuals > 1 > cash Flow > cash From Investing
-470000
Annuals > 1 > cash Flow > cash From Financing
68130000
Annuals > 1 > cash Flow > net Change In Cash
34204000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.3504320861919743
Annuals > 1 > ratios > PB
-6.444175045205938
Annuals > 1 > ratios > ROE
50.654369907355736
Annuals > 1 > ratios > ROA
-41.9090825137369
Annuals > 1 > ratios > FCF
-33918000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-09-30
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
342000
Annuals > 2 > income Statement > gross Profit
-342000
Annuals > 2 > income Statement > operating Expenses
28850000
Annuals > 2 > income Statement > operating Income
-29192000
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-27710000
Annuals > 2 > income Statement > net Income
-27710000
Annuals > 2 > income Statement > eps
-1.0835070750548597
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
25574360
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-27368000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1482000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
48344000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
546000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
49220000
Annuals > 2 > balance Sheet > property Plant Equipment
1579000
Annuals > 2 > balance Sheet > total Assets
50854000
Annuals > 2 > balance Sheet > payables
1606000
Annuals > 2 > balance Sheet > short Term Debt
283000
Annuals > 2 > balance Sheet > long Term Debt
9465000
Annuals > 2 > balance Sheet > total Liabilities
89260000
Annuals > 2 > balance Sheet > equity
-38406000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-27710000
Annuals > 2 > cash Flow > depreciation
342000
Annuals > 2 > cash Flow > change In Working Capital
4579000
Annuals > 2 > cash Flow > cash From Operations
-20394000
Annuals > 2 > cash Flow > capital Expenditures
732000
Annuals > 2 > cash Flow > cash From Investing
-732000
Annuals > 2 > cash Flow > cash From Financing
43789000
Annuals > 2 > cash Flow > net Change In Cash
22639000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.0835070750548597
Annuals > 2 > ratios > PB
-11.440074592511586
Annuals > 2 > ratios > ROE
72.15018486694788
Annuals > 2 > ratios > ROA
-54.48932237385456
Annuals > 2 > ratios > FCF
-21126000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-09-30
Annuals > 3 > income Statement > revenue
210000
Annuals > 3 > income Statement > cost Of Revenue
145000
Annuals > 3 > income Statement > gross Profit
65000
Annuals > 3 > income Statement > operating Expenses
12121000
Annuals > 3 > income Statement > operating Income
-12056000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-9187000
Annuals > 3 > income Statement > net Income
-9187000
Annuals > 3 > income Statement > eps
-0.35922697576791757
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
25574360
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-9042000
Annuals > 3 > income Statement > operating Margin
-5740.952380952381
Annuals > 3 > income Statement > total Other Income Expense Net
2869000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
25705000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1743000
Annuals > 3 > balance Sheet > inventories
0
Annuals > 3 > balance Sheet > total Current Assets
27684000
Annuals > 3 > balance Sheet > property Plant Equipment
1060000
Annuals > 3 > balance Sheet > total Assets
28794000
Annuals > 3 > balance Sheet > payables
600000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
41272000
Annuals > 3 > balance Sheet > equity
-12478000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-9187000
Annuals > 3 > cash Flow > depreciation
145000
Annuals > 3 > cash Flow > change In Working Capital
-572000
Annuals > 3 > cash Flow > cash From Operations
-9262000
Annuals > 3 > cash Flow > capital Expenditures
680000
Annuals > 3 > cash Flow > cash From Investing
-680000
Annuals > 3 > cash Flow > cash From Financing
31688000
Annuals > 3 > cash Flow > net Change In Cash
21696000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.35922697576791757
Annuals > 3 > ratios > PB
-35.211372399422984
Annuals > 3 > ratios > ROE
73.62558102259977
Annuals > 3 > ratios > ROA
-31.905952629019936
Annuals > 3 > ratios > FCF
-9942000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-47.34285714285714
Annuals > 3 > health Score
31
Valuation > metrics > PE
-0.523206906729634
Valuation > metrics > PB
4.174069937341448
Valuation > final Score
38.259300626585514
Valuation > verdict
39.1% Overvalued
Profitability > metrics > ROE
-12.711887196679724
Profitability > metrics > ROA
-10.169382135276232
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.31776580582123937
Risk > metrics > Interest Coverage
-23.001538461538463
Risk > final Score
-32
Risk > verdict
High
Liquidity > metrics > Current Ratio
43.89298079949638
Liquidity > metrics > Quick Ratio
43.89298079949638
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
42.31347356821055
Prev Valuations > 1
46.591288031287746
Prev Valuations > 2
49.38933706589198
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-56
Prev Risks > 1
-45
Prev Risks > 2
-144
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:23:33.588Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-20
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.66
Earnings History > 0 > eps Difference
0.66
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-12
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.52
Earnings History > 1 > eps Estimate
-0.64
Earnings History > 1 > eps Difference
0.12
Earnings History > 1 > surprise Percent
18.75
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-13
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.65
Earnings History > 2 > eps Estimate
-0.6
Earnings History > 2 > eps Difference
-0.05
Earnings History > 2 > surprise Percent
-8.3333
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-15
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.56
Earnings History > 3 > eps Estimate
-0.57
Earnings History > 3 > eps Difference
0.01
Earnings History > 3 > surprise Percent
1.7544
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-20
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.52
Earnings History > 4 > eps Estimate
-0.55
Earnings History > 4 > eps Difference
0.03
Earnings History > 4 > surprise Percent
5.4545
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-13
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.62
Earnings History > 5 > eps Estimate
-0.56
Earnings History > 5 > eps Difference
-0.06
Earnings History > 5 > surprise Percent
-10.7143
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-13
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.6
Earnings History > 6 > eps Estimate
-0.53
Earnings History > 6 > eps Difference
-0.07
Earnings History > 6 > surprise Percent
-13.2075
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-14
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.76
Earnings History > 7 > eps Estimate
-0.46
Earnings History > 7 > eps Difference
-0.3
Earnings History > 7 > surprise Percent
-65.2174
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-21
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-7.77
Earnings History > 8 > eps Estimate
-1.67
Earnings History > 8 > eps Difference
-6.1
Earnings History > 8 > surprise Percent
-365.2695
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties, which is in Phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor that is in Phase 2 proof-of-concept (POC) trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist, which is in Phase 2 POC trial to treat patients with MDD and higher levels of anhedonia; and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor that is in Phase 1 clinical trial for the treatment of MDD. The company was incorporated in 2019 and is headquartered in Mountain View, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShort Interest in Alto Neuroscience, Inc. (NYSE:ANRO) Drops By 21.0% MarketBeat
Read more →Alto Neuroscience, Inc. (NYSE:ANRO) Given Average Recommendation of “Moderate Buy” by Brokerages Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$31.125
Analyst Picks
Strong Buy
6
Buy
1
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bearish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Alto Neuroscience, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.66
Date
2025-09-30
EPS Actual
-0.52
EPS Estimate
-0.64
EPS Difference
0.12
Surprise Percent
18.75%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.